In a tentative agreement, pharmaceutical giant Johnson & Johnson is on track to pay approximately $700 million to settle an investigation involving over 40 U.S. states. The claims allege that the company wrongfully marketed its talc-based baby powder without adequately warning consumers about potential health risks. Individuals familiar with the deal revealed that the initial offer to settle all current and future baby powder claims amounted to $9 billion during the bankruptcy filing of one of the company's units.